232 related articles for article (PubMed ID: 22093581)
1. Diagnostic and prognostic value of cytogenetics in acute myeloid leukemia.
Grimwade D; Mrózek K
Hematol Oncol Clin North Am; 2011 Dec; 25(6):1135-61, vii. PubMed ID: 22093581
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.
Ghanem H; Tank N; Tabbara IA
Am J Hematol; 2012 Jan; 87(1):69-77. PubMed ID: 22072438
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetics of pediatric acute myeloid leukemia.
Manola KN
Eur J Haematol; 2009 Nov; 83(5):391-405. PubMed ID: 19563518
[TBL] [Abstract][Full Text] [Related]
4. [Pathobiology of acute myeloid leukemia].
Christ O; Feuring-Buske M; Hiddemann W; Buske C
Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.
Mrózek K; Heinonen K; Bloomfield CD
Int J Hematol; 2000 Oct; 72(3):261-71. PubMed ID: 11185980
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics in acute leukemia.
Mrózek K; Heerema NA; Bloomfield CD
Blood Rev; 2004 Jun; 18(2):115-36. PubMed ID: 15010150
[TBL] [Abstract][Full Text] [Related]
7. Genetic classification of acute myeloid leukemia (AML).
Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Ann Hematol; 2004; 83 Suppl 1():S97-100. PubMed ID: 15124693
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
9. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
Baldus CD; Bullinger L
Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic abnormalities in adult non-promyelocytic acute myeloid leukemia: a concise review.
Marchesi F; Annibali O; Cerchiara E; Tirindelli MC; Avvisati G
Crit Rev Oncol Hematol; 2011 Dec; 80(3):331-46. PubMed ID: 21123080
[TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of acute myeloid leukemia: from chromosomal aberrations to biologically targeted therapy.
Lübbert M; Müller-Tidow C; Hofmann WK; Koeffler HP
J Cell Biochem; 2008 Aug; 104(6):2059-70. PubMed ID: 18613031
[TBL] [Abstract][Full Text] [Related]
12. Impact of karyotype on treatment outcome in acute myeloid leukemia.
Grimwade D; Moorman A; Hills R; Wheatley K; Walker H; Harrison G; Harrison Ch; Goldstone A; Burnett A;
Ann Hematol; 2004; 83 Suppl 1():S45-8. PubMed ID: 15124668
[TBL] [Abstract][Full Text] [Related]
13. Unfavorable-risk cytogenetics in acute myeloid leukemia.
Hong WJ; Medeiros BC
Expert Rev Hematol; 2011 Apr; 4(2):173-84. PubMed ID: 21495927
[TBL] [Abstract][Full Text] [Related]
14. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia.
Verhaak RG; Valk PJ
Cancer Treat Res; 2010; 145():67-83. PubMed ID: 20306246
[TBL] [Abstract][Full Text] [Related]
15. [Long-term survival results according to cytogenetic risk in patients with acute myeloid leukemia--singl center experience].
Piatkowska-Jakubas B; Mensah-Glanowska P; Salamańczuk Z; Skotnicki AB
Przegl Lek; 2011; 68(6):291-5. PubMed ID: 22039664
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemia.
Fröhling S; Kayser S; Mayer C; Miller S; Wieland C; Skelin S; Schlenk RF; Döhner H; Döhner K;
Haematologica; 2005 Feb; 90(2):194-9. PubMed ID: 15710571
[TBL] [Abstract][Full Text] [Related]
17. Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insights.
Bullinger L; Fröhling S
Semin Oncol; 2012 Feb; 39(1):37-46. PubMed ID: 22289490
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostics, classification and prognostic criteria of acute myeloid leukemia].
Heilmeier B; Buske C; Spiekermann K; Bohlander S; Feuring-Buske M; Hiddemann W; Braess J
Med Klin (Munich); 2007 Apr; 102(4):296-308. PubMed ID: 17426933
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization.
Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902
[TBL] [Abstract][Full Text] [Related]
20. Specific chromosomal aberrations in de novo acute myeloid leukemia: a comparative analysis of results with a report of three novel chromosomal rearrangements t(7;14)(q35;q13), t(8;18)(p11.2;q12), t(13;15) in Indian population.
Ahmad F; Dalvi R; Das BR; Mandava S
Cancer Detect Prev; 2008; 32(2):168-77. PubMed ID: 18639991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]